期刊文献+

HPLC手性固定相法测定血浆中氟西汀对映体的浓度

Determination of Enantiomers of Fluoxetine in Plasma by HPLC-Chiral Stationary Phase
原文传递
导出
摘要 目的:建立以高效液相色谱手性固定相法测定血浆中氟西汀对映体浓度的方法。方法:采用Chirobiotic V手性色谱柱,流动相为甲醇-冰醋酸-三乙胺(100:0.04:0.04),检测波长为226nm,流速为1mL·min^-1内标为氯氮平。结果:R-去甲氟西汀和S-去甲氟西汀对氟西汀对映体和内标的分离没有干扰。R-氟西汀、S-氟西汀检测浓度分别在8.1~432(r=0.9998)、10.8~432(r=0.9992)ng·mL^-1范围内线性关系良好;其相对回收率分别为97.2%~101.9%和98.7%~102.2%,日内RSD分别为2.6%~5.3%和2.1%~6.7%,日间RSD分别为7.7%~8.9%和8.0%~10.6%。结论:本试验所建立的方法简便、可靠、灵敏度高,可用于血浆中R-氟西汀和S-氟西汀的血药浓度测定及对映体的药动学研究。 OBJECTIVE: To establish an HPLC-CSP (chiral stationary phase) for the determination of plasma levels of enantiomers of fluoxetine. METHODS: Enantiomers of fluoxetine were separated on a Chirobiotic V column. The mobile phase consisted of methanol - acetic acid - triethylamine (100 : 0.04 : 0.04) with a flow rate of 1 mL · min^ -1. The detection wavelength was set at 226 nm.Clozapine was used as the internal standard. RESULTS: Under this chromatographic condition, both R - norfluoxetine and S - norfluoxetine had no interference on the enantiomers of fluoxetine and the internal standard. The calibration curve was linear in the range of 8.1-432 ng · mL^-1( r = 0.999 8) for R- enantiomer and in the range of 10.8-432 ng · mL^ -1 ( r = 0.999 2) for S - enantiomer. The relative recovery of R - fluoxetine and S - fluoxetine in plasma were 97.2% - 101.9% and 98.7%- 102.2% , respectively. RSD of intraday and interday ranged from 2.6% to 5.3% and from 7.7% to 8.9% for R- fluoxetine, and from 2.1% to 6.7% and from 8.0% to 10.6% for S- fuoxetine, respectively. CONCLUSION: The method is simple, reliable and sensitive, and applicable for the determination and pharmacokinetic study of the enantiomers of fluoxetine in plasma.
出处 《中国药房》 CAS CSCD 北大核心 2008年第17期1308-1310,共3页 China Pharmacy
关键词 高效液相色谱法 手性固定相法 氟西汀 对映体 血药浓度 HPLC Chiral stationary phase Fluoxetine Enantiomers Blood drug concentration
  • 相关文献

参考文献8

  • 1严明.抗抑郁药氟西汀的临床应用[J].中国临床康复,2004,8(21):4348-4349. 被引量:4
  • 2李玲,袁波,朱荣申,贾松.高效液相色谱法检测抑郁症患者血清中氟西汀的浓度[J].中国药学杂志,2002,37(11):855-857. 被引量:9
  • 3Guo X, Fukushima T, Li F, et al .Determination of fluoxetine and norfluoxetine in rat plasma by HPLC with pre - column derivatization and fluorescence detection [J ]. Biomed Chromatogr ,2003,17(1) : 1.
  • 4Eap CB, Bondolfi G, Zullino D, et al .Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers[J] .J Clin Psychopharmacol ,2001,21(3) :330.
  • 5Olsen BA, Wirth DD, Larew JS. Determination of fluoxetine hydrochloride enantiomeric excess using high - performance liquid chromatography with chiral stationary phases[J ]. J Pharrn Biorned Anal, 1998,17(4) :623.
  • 6Unceta N, Barrondo S, de Azua IR,et al .Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection[J] .J Chrornatogr B Analyt Technol Biorned Life Sci , 2007,852(1-2) :519.
  • 7Shen Z, Wang S, Bakhtiar R. Enantiomeric separation and quantification of fluoxetine (Prozac) in human plasma by liquid chromatography tandem mass spectrometry using liquid - liquid extraction in 96- well plate format[J]. Rapid Cornrnun Mass Spectrorn, 2002, 16(5) :332.
  • 8Gatti G, Bonomi I, Marchiselli R. Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography[J ] .J Chrornatogr B Analyt Technol Biomed Life Sci ,2003,784(2) :375.

二级参考文献14

  • 1[1]Saletu B,Grunberger T.Classification and determination of cerebral bioavailability of fluoxetine:pharmacokinetic,pharmoco-EEG,and psychonetric anailsis[J].Clin Psychiatry,1985,46:45.
  • 2[2]Crisfasi JA,Le NX,Long C.Simultaneous identification and quantitation of fluoxetine and its metabolite,norfluoxetine,in biological samples by GC-MS[J].Analytical Toxicology,1997,21(6):415.
  • 3[3]Nichols JH,Charlson JR,Lawson GM.Automated HPLC assay of fluoxetine and norfluoxetine in serum[J].Clin Chem,1994,40:1312.
  • 4[2]Elkin I,Shea MT,Watkins JT,et al.Nutional institute of mental health teatment of depression CoUaborative research progam:General effeetiveness of treatments.Aroh Gen Psychiatry 2002;46:971-83
  • 5[4]Fontaine K,Chouinard G Fluoxitine in the lon-term maintenance treatment of obsesive compulsive disorder.Bychiatric Ammals 2002;19:88-91
  • 6[5]Mantogomerg SA.The efficacy of fluoxetine as an antidepressant in the short and long term.Int Clin Psychopharmacol 2003;4:113-9
  • 7[6]Hamilton M.The clinicad distinction between anxiety and depression.Br J Clin Pharmalol 2002;15:1665-99
  • 8[8]Fisch C.Effect of fluoxetine on the electrocardiogram.J Clin Psychiatry 2001;46:42-4
  • 9[9]Montgomery SA,Dufour H,Brion S,et al.The Prophylactic erricacy of fluoxetine in unipolar depresaion.Br J Psychiatry 2003;153:69-76
  • 10[10]Sohweizer E,Rickels KA,msterdam JD,et al.What constitutes and adequate antideprassant trial for fluoxetine? J Clin Psychiatry 1990;51:8-11

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部